Skip to content

Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity

Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04361266
Enrollment
0
Registered
2020-04-24
Start date
2022-08-01
Completion date
2023-11-01
Last updated
2022-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Injuries, Rotator Cuff Syndrome of Shoulder and Allied Disorders, Rotator Cuff Tears

Brief summary

The purpose is to assess Rotium, a novel nanoscaffold, impact on healing of a repaired rotator cuff and compare to a repair without Rotium. Animal (sheep) models have shown both quicker and more organized healing when Rotium is used, but there are no studies to confirm these outcomes translate to human population. Hypothesis: Rotium rotator cuff repairs will heal both quicker and better than traditional rotator cuff repair techniques.

Detailed description

Patients indicated for rotator cuff repair surgery will be offered participation within the study and consented accordingly. A copy of the consent will be provided to the participant. A preoperative ultrasonographic assessment will occur by Dr. Onishi. A randomization process by computer program will determine patients who have Rotium augmented repairs, or not. The patients will not be blinded. The surgery will be carried out by a single surgeon making all aspects uniform, except if there is or is not a Rotium patch. The Rotium patch will be implanted in accordance to standards of handling sterile implants and placed in a manner that is consistent to its FDA approval. The patch will be furnished by the institution where the surgery is being performed. Digital photography will document pertinent arthroscopic operative findings per standard of care. Participant assessment will commence preoperatively in an outpatient clinic then continue in postoperative period, occurring at 2, 4, 6 weeks and 3, 6 and 12 month intervals. During each visit, the participants will be assessed by two clinicians: the principal investigator and a blinded ultrasonographer. Preoperative assessment will include obtaining baseline patient reported outcomes (UCLA, Rowe, Constant, American Shoulder and Elbow Surgeons (ASES) score and SANE (Single Alpha Numeric Evaluation)scores) by paper questionnaire. A medical history will document NSAID use, cortisone injections about the shoulder, tobacco usage, narcotic medicine consumption, and pregnancy status. Due to their deleterious effects on healing, all patients will be instructed to not take NSAIDs in the first 6 weeks postoperative. Noncompliance will be noted, but not disqualify the participant from study. Smoking cessation will be strongly encouraged. A shoulder physical examination will be performed; specifically range of motion assessment in multiple planes (frontal flexion, internal and external rotation at 90 degrees of abduction and at side), rotator cuff muscle strength testing with the scapula stabilized, scapula posture observed, and provocative tests for impingement syndrome. Medical records will be reviewed. This evaluation will be performed by the principal investigator and will take 45-60 minutes. The participant will undergo a separate diagnostic ultrasonographic assessment of the rotator cuff tendons by blinded ultrasonographer. This will take 15-30 minutes. Aftercare of each population will be identical and will include a 6-week period of sling immobilization, brief perioperative narcotic medicine, and physical therapy. Physical therapy protocols will be identical. The participants will be treated by a variety of physical therapists. All physical therapy will occur out of the home at a PT clinic. Additional home exercises will be furnished and will be independently performed by the participants. Specifically, at the 2-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, VAS pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder assessed (frontal flexion and external rotation at the side), and the examine will exclude any complications. Physical therapy for shoulder passive range of motion and periscapular strengthening will be prescribed, home exercise sheet provided, and the abduction portion of the sling will be discontinued. Shoulder radiographs will be performed. This visit will take 15-30 minutes. In addition and separate to this,blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. Vascularity using superb microvascular imaging and standard ultrasound techniques will assess vascularity and rotator cuff repair integrity. If possible, elastography will be performed. These images will be stored in de-identified manner within University of Pittsburgh HIPPA-compliant cloud. This will take 15-30 minutes and may be done at a separate time. At the 4-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder (frontal flexion and external rotation at the side) assessed, and the examine will exclude any complications. The prior physical therapy and home exercises will be continued. This visit will take 15-30 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time. At the 6-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder (frontal flexion, internal and external rotation at 90 degrees of abduction and at side) assessed, and the examine will exclude any complications. The sling will be discontinued and new physical therapy and home exercises will be provided; therapy will include shoulder passive range of motion and periscapular strengthening and include rotator cuff strengthening progressing from isometric to concentric then to eccentric with the pace being determined by a physical therapist, but done in a pain free manner. Additionally, patient reported outcomes (UCLA, Rowe, Constant, ASES and SANE scores) will be collected. This visit will take 30-45 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time. At the 3-, 6- and 12-month postoperative visits a history will be obtained to assess shoulder functionality/limitations, quantify NSAID usage, pain score, and assess for any complications. The examination will be similar to the 6-week evaluation, except rotator cuff specific strength will be assessed similar to the preoperative testing. Necessity of ongoing physical therapy will be considered and ordered appropriately. Home exercises will be continued. These visits will take 30-45 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time.

Interventions

DEVICERotium nanoscaffold

Rotium bioabsorbable nanoscaffold placed between bone-tendon interface of rotator cuff repair construct

PROCEDUREControl arm rotator cuff repair

Standard rotator cuff repair without Rotium

Sponsors

Atreon Orthopedics
CollaboratorINDUSTRY
Joshua Szabo, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

Blinded ultrasound assessment

Intervention model description

prospective randomized control trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* -symptomatic supraspinatus or supraspinatus and infraspinatus tear that can be repaired to the greater tuberosity in an anatomical manner using a dual layer repair technique. * also included will be patients that have concomitant pathology addressed at time of surgery, specifically pathologies of the biceps tendon (tenodesis or tenotomy), arthrosis of the acromioclavicular joint (distal clavicle resection), or labral tearing (debridement or repair) * included age range of subjects will be from 18-80 years old

Exclusion criteria

* diabetes, cancer or medical states that may impair healing, such as organ transplantation or systemic inflammatory process treated with immune modulating drugs (chemotherapy, immunosuppression drugs) * prior surgery to the ipsilateral rotator cuff tendon * need of soft tissue releases to accomplish an anatomic repair, partial repairs and/or concomitant subscapularis repair * significant glenohumeral arthritis * active or ongoing infection * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Rotator cuff repair integrity @ 3 monthspostoperative 3 monthsultrasound assessment of rotator cuff
Rotator cuff integrity baseline/preoperativepreoperativeultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 2 weekspostoperative at 2 weeksultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 4 weekspostoperative at 4 weeksultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 6 weekspostoperative at 6 weeksultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 12 monthspostoperative at 12 monthsultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 6 monthspostoperative at 6 monthsultrasound assessment of rotator cuff
Postoperative rotator cuff vascularity during healingpostoperative at 2 weeksultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)

Secondary

MeasureTime frameDescription
SANE scorepreoperative and postoperative at 2,4, 6 weeks and 3,6,12 months postoperativeOutcome score
University California Los Angeles Shoulder scorepreoperative and postoperative at 6 weeks and 3,6,12 months postoperativeOutcome score
Rowe scorepreoperative and postoperative at 6 weeks and 3,6,12 months postoperativeOutcome score
Constant scorepreoperative and postoperative at 6 weeks and 3,6,12 months postoperativeOutcome score
American shoulder and elbow surgeons scorepreoperative and postoperative at 6 weeks and 3,6,12 months postoperativeOutcome score

Other

MeasureTime frameDescription
Tobacco usagepreoperative and postoperative periods @ 2,4, 6 weeks and 3, 6, 12 monthsDaily consumption
Narcotic consumptionpostoperative period @ 2,4, 6 weeks and 3, 6, 12 monthstotal dosage of narcotic medicine
Cortisone injections about the shoulderpreoperative periodInclude total number and timeframe relative to surgical date
NSAID usagepostoperative period @ 2,4, 6 weeks and 3, 6, 12 monthstotal dosage of NSAIDs

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026